Ticagrelor breaks up the tumor-platelet party

Annachiara Mitrugno, Owen J.T. McCarty

Research output: Contribution to journalComment/debatepeer-review

9 Scopus citations


In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1

Original languageEnglish (US)
Pages (from-to)1177-1178
Number of pages2
Issue number10
StatePublished - Sep 7 2017

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Ticagrelor breaks up the tumor-platelet party'. Together they form a unique fingerprint.

Cite this